09 Jun 2020

New Pharma Plant to Be Constructed in Moscow

Share this
To favorites

R-Opra, a Technopolis Moscow Special Economic Zone resident, manufactures drugs and is localizing its production in Moscow within the second offset contract. The plant construction has been started this year.

The offset contract will enable to set up another modern innovative import-substituting production facility in Moscow. The company will manufacture demanded drugs which are mostly not being produced in Russia now.

RELATED MATERIALS

In more detail
18 Jan
Non-resource Non-Energy Exports from Moscow to Kazakhstan Exceeded USD 2 Bn
In more detail
13 Jan
Five More Sites of Former Industrial Zones Will Be Redeveloped
In more detail
30 Dec
Muscovites Bought 2.5 Times More Parking Spaces from City in 2020
Integrated Development Will Allow to Plan Ecosystem for Industrial Zones
Gen Terra
The Kalibr Technopark in Moscow accommodates the only Russian industrial manufacturer of chemicals for molecular biology. In his interview to the Moscow Investment Portal, Gen Terra director Vladimir Survilo talked about DNA, genome sequencing and plans to conquer the international market.
Exacte Labs
There is an opinion that technoparks are focused exclusively on industrial production or IT-technologies. However, they can be an ideal place for companies with different profiles. So, the Slava technopark accommodates the Exacte Labs laboratory center performing medicinal product analyses and medical tests. General Director Vasily Kazey told the Investportal about their research subject and unusual name, as well as a little about India.
All topics